These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22878250)

  • 61. [Treatment of vancomycin-resistant Enterococcus with linezolid in paediatric hospitals].
    Travaglianti M; Pérez M; Sberna N; Rousseau M; Calle G; Gómez S
    Farm Hosp; 2007; 31(1):43-7. PubMed ID: 17439313
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Evaluation of vancomycin-resistant Enterococcus cases at a tertiary level hospital in Izmir, Turkey].
    Atalay S; Ece G; Samlıoğlu P; Maraş G; Köse I; Köse S
    Mikrobiyol Bul; 2012 Oct; 46(4):553-9. PubMed ID: 23188569
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Topical linezolid 0.2% for the treatment of vancomycin-resistant or vancomycin-intolerant gram-positive bacterial keratitis.
    Tu EY; Jain S
    Am J Ophthalmol; 2013 Jun; 155(6):1095-1098.e1. PubMed ID: 23453280
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Linezolid update: stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms.
    Mendes RE; Deshpande LM; Jones RN
    Drug Resist Updat; 2014 Apr; 17(1-2):1-12. PubMed ID: 24880801
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Peritoneal dialysis fluid concentrations of linezolid in the treatment of vancomycin-resistant Enterococcus faecium peritonitis.
    DePestel DD; Peloquin CA; Carver PL
    Pharmacotherapy; 2003 Oct; 23(10):1322-6. PubMed ID: 14594349
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Leuconostoc lactis- A Rare Cause of Bacterial Meningitis in an Immunocompromised Host.
    Omori R; Fujiwara S; Ishiyama H; Kuroda H; Kohara N
    Intern Med; 2020; 59(22):2935-2936. PubMed ID: 33191371
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Emergence of linezolid-resistant Enterococcus faecium during treatment of enterococcal infections.
    Bassetti M; Farrel PA; Callan DA; Topal JE; Dembry LM
    Int J Antimicrob Agents; 2003 Jun; 21(6):593-4. PubMed ID: 12791477
    [No Abstract]   [Full Text] [Related]  

  • 68. Linezolid resistant enterococcus faecium.
    McNicholas S; Hanahoe B; Higgins F; McAnena O; Corbett-Feeney G; Cormican M
    Ir Med J; 2008; 101(7):225-6. PubMed ID: 18810787
    [No Abstract]   [Full Text] [Related]  

  • 69. Linezolid- and vancomycin-resistant Enterococcus faecium endocarditis: successful treatment with tigecycline and daptomycin.
    Jenkins I
    J Hosp Med; 2007 Sep; 2(5):343-4. PubMed ID: 17935250
    [No Abstract]   [Full Text] [Related]  

  • 70. Spectrum of gram-positive bacteraemia and in vitro activities of daptomycin, linezolid and vancomycin against organisms isolated from cancer patients.
    Rolston KV; Kapadia M; Tarrand J; Coyle E; Prince RA
    Int J Antimicrob Agents; 2013 Jun; 41(6):516-20. PubMed ID: 23481658
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Quinupristin-dalfopristin and linezolid: evidence and opinion.
    Eliopoulos GM
    Clin Infect Dis; 2003 Feb; 36(4):473-81. PubMed ID: 12567306
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Linezolid: a review of its use in the management of serious gram-positive infections.
    Perry CM; Jarvis B
    Drugs; 2001; 61(4):525-51. PubMed ID: 11324682
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Treatment of prosthetic valve infective endocarditis due to multi-resistant Gram-positive bacteria with linezolid.
    Wareham DW; Abbas H; Karcher AM; Das SS
    J Infect; 2006 Apr; 52(4):300-4. PubMed ID: 16099052
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Vancomycin resistant enterococci in etiology of neutropenic enterocolitis: prophylaxis, clinical signs and treatment].
    Ptushkin VV
    Antibiot Khimioter; 2006; 51(6):11-4. PubMed ID: 17523416
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Gut overgrowth of vancomycin-resistant enterococci (VRE) results in linezolid-resistant mutation in a child with severe congenital neutropenia: a case report.
    Verma N; Clarke RW; Bolton-Maggs PH; van Saene HK
    J Pediatr Hematol Oncol; 2007 Aug; 29(8):557-60. PubMed ID: 17762497
    [TBL] [Abstract][Full Text] [Related]  

  • 76. In vitro activity of linezolid against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae.
    Patel R; Rouse MS; Piper KE; Steckelberg JM
    Diagn Microbiol Infect Dis; 1999 Jun; 34(2):119-22. PubMed ID: 10354862
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Successful treatment of persistent vancomycin-resistant Enterococcus faecium bacteremia with linezolid and gentamicin.
    Noskin GA; Siddiqui F; Stosor V; Kruzynski J; Peterson LR
    Clin Infect Dis; 1999 Mar; 28(3):689-90. PubMed ID: 10194104
    [No Abstract]   [Full Text] [Related]  

  • 78. [Pattern dynamics of bacteriemia and sepsis pathogens in ICU patients of emergency service].
    Chernen'kaia TV; Borisova LA; Aleksandrova IV; Reĭ SI; Nikitina OV; Kosolapov DA
    Antibiot Khimioter; 2013; 58(5-6):11-6. PubMed ID: 24757820
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The clinical impact of linezolid susceptibility reporting in patients with vancomycin-resistant enterococci.
    Scheetz MH; Qi C; Noskin GA; Warren JR; Postelnick MJ; Malczynski M; Huang J; Zembower TR
    Diagn Microbiol Infect Dis; 2006 Dec; 56(4):407-13. PubMed ID: 16930924
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Emergence of linezolid resistance in the vancomycin-resistant Enterococcus faecium multilocus sequence typing C1 epidemic lineage.
    Bonora MG; Solbiati M; Stepan E; Zorzi A; Luzzani A; Catania MR; Fontana R
    J Clin Microbiol; 2006 Mar; 44(3):1153-5. PubMed ID: 16517918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.